Rosenblatt raised Apple Inc. (NASDAQ: AAPL) price target from $160 to $189. Rosenblatt analyst Barton Crockett also upgraded the stock from Neutral to Buy. Apple shares fell 2.3% to $146.33 in pre-market trading.
Gainers
PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.